LobbyingThe American College of Medical Genetics and Genomics lobbying by quarter
The American College of Medical Genetics and Genomics's latest lobbying report covers Q2 2026, at $30K. The four quarters Q4 2025–Q3 2026 total $90K. Its first report covers Q2 2024; the issues it reports most are Health Issues.
The American College of Medical Genetics and Genomics
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $90K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q2 2024
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2024 | $30K | 1 |
| Q3 2024 | $30K | 1 |
| Q4 2024 | $30K | 1 |
| Q1 2025 | $30K | 1 |
| Q2 2025 | $30K | 1 |
| Q3 2025 | $30K | 1 |
| Q4 2025 | $30K | 1 |
| Q1 2026 | $30K | 1 |
| Q2 2026 | $30K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$270K · 9 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Food & Drug Administration (FDA)9 reports
- HOUSE OF REPRESENTATIVES9 reports
- Office of Management & Budget (OMB)9 reports
- SENATE9 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseThe American College of Medical Genetics and Genomics | $270K | 9 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 06/29for Q2 | In-house | $30K |
| 04/01for Q1 | In-house | $30K |
| 01/09for Q4 2025 | In-house | $30K |
| 25/10/02for Q2 2024 | In-house | Under $5,000 |
| 25/10/02for Q3 2025 | In-house | $30K |
| 25/07/01for Q2 2025 | In-house | $30K |
| 25/04/01for Q1 2025 | In-house | $30K |
| 25/01/08for Q4 2024 | In-house | $30K |
| 24/10/02for Q3 2024 | In-house | $30K |
| 24/07/19for Q2 2024 | In-house | $30K |
| 24/04/29for Q2 2024 | In-house | Under $5,000 |